CAMBRIDGE, United Kingdom — Modern medicine has become increasingly focused on preventing disease and extending healthy life, but a new paper claims that the next major leap in healthcare will require something more fundamental: ensuring that both medical care and scientific knowledge are accessible to everyone.
In Frontiers in Medicine, Dr. Chris Macdonald of the University of Cambridge proposes a new conceptual framework, Medicine 4.0, extending the increasingly influential concept of "Medicine 3.0" by introducing a third dimension to healthcare: radical access.
Where Medicine 3.0 emphasizes prevention, personalized care, risk management, and maximizing healthspan, Medicine 4.0 argues that these advances cannot achieve their full societal impact if access to healthcare services and scientific ideas remains constrained.
"Medical progress should not be measured solely by how advanced our technologies become," says Dr Macdonald. "It should also be judged by how widely those advances are shared and how freely transformative scientific ideas can be explored."
The paper proposes visualizing modern healthcare as three dimensions rather than two. Lifespan and healthspan remain central, but a third axis (access) captures the extent to which healthcare systems ensure equitable access to treatment while allowing promising scientific ideas to be investigated without unnecessary structural barriers.
Beyond prevention
The article argues that many highly effective preventive tools already exist but remain inaccessible to millions of people because of economic, geographic, or structural barriers. In high-income countries, advanced preventive care often depends on private healthcare or expensive insurance, while many lower-income regions continue to face limited access to essential medicines, vaccinations, clean water, and primary healthcare infrastructure.
According to the paper, innovation alone is insufficient if the resulting benefits reach only a privileged minority.
Scientific inquiry also needs access
Medicine 4.0 extends the concept of access beyond healthcare delivery to scientific research itself.
The paper examines how regulatory environments, funding mechanisms, political pressures, cultural attitudes, and commercial incentives can influence which scientific questions receive attention. As one historical example, the paper discusses decades of limited psychedelic research before renewed clinical investigation revealed therapeutic potential for conditions including post-traumatic stress disorder, depression, alcohol use disorder, and end-of-life anxiety. The author argues that this illustrates the importance of allowing scientific inquiry to proceed on the basis of evidence rather than external pressures, while emphasizing that rigorous clinical evaluation remains essential before new treatments are adopted.
Incentives shape healthcare
The paper also examines how financial incentives can influence healthcare priorities. It argues that healthcare systems naturally respond to the incentives built into them, meaning prevention, long-term public health, and lower-cost interventions may receive less emphasis than activities that generate more immediate financial returns.
Rather than attributing these outcomes to individual actors, the paper focuses on systemic incentive structures and argues for designing healthcare systems that better reward long-term improvements in population health.
A warning for digital health
As artificial intelligence, digital health platforms, and health-monitoring technologies become increasingly common, the author argues that they offer an unprecedented opportunity to democratize preventive healthcare at relatively low cost.
However, the paper cautions that widespread reliance on subscription models, paywalls, or advertising-based business models could reinforce existing health inequalities rather than reduce them.
Returning to the scientific method
The paper concludes by drawing inspiration from the philosopher Francis Bacon, arguing that science should remain focused on improving the human condition by continually challenging assumptions and removing unnecessary barriers to discovery.
Medicine 4.0, the author argues, is ultimately "about building a healthcare system that is more open, more accessible, and fundamentally more scientific."
Journal
Frontiers in Medicine
Article title
"Medicine 4.0: the era of revolutionary access"
Author
Dr Chris Macdonald. Fellow at Lucy Cavendish College, University of Cambridge.
Link to article
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2026.1903811/full
DOI
https://doi.org/10.3389/fmed.2026.1903811
